Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
8h
GlobalData on MSNGLP-1RAs and opioid use disorder: a new frontier in addiction treatmentGlucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...
Artificial sweeteners are everywhere, marketed as a healthier alternative to sugar, but new research suggests they may not be ...
A study published in Cell Metabolism looks at the artificial sweetener aspartame, insulin levels and blood inflammation in mice. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary ...
Man, 52, ‘cured’ of his 15-year cocaine habit after taking weight loss jab in first case of its kind
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results